These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32290045)

  • 1. Is Initial Misdiagnosis Associated with Reaching Disability Milestones in Patients with Multiple Sclerosis?
    Ivaniuk A; Marusich T; Solodovnikova Y; Son A
    Medicina (Kaunas); 2020 Apr; 56(4):. PubMed ID: 32290045
    [No Abstract]   [Full Text] [Related]  

  • 2. The impairment of the functional system and fatigue at the onset of the disease predict reaching disability milestones in relapsing-remitting multiple sclerosis differently in female and male patients.
    Ivaniuk A; Solodovnikova Y; Marusich T; Son A
    Acta Neurol Belg; 2021 Dec; 121(6):1699-1706. PubMed ID: 32997326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the Risk of Reaching Multiple Sclerosis Disability Milestones In Recent Decades: A Nationwide Population-Based Cohort Study in Sweden.
    Beiki O; Frumento P; Bottai M; Manouchehrinia A; Hillert J
    JAMA Neurol; 2019 Jun; 76(6):665-671. PubMed ID: 30882868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of the multiple sclerosis functional composite in follow-up: relationship to disease phenotype, disability and treatment strategies.
    Ozakbas S; Ormeci B; Idiman E
    J Neurol Sci; 2005 May; 232(1-2):65-9. PubMed ID: 15850584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients.
    Rzepiński Ł; Zawadka-Kunikowska M; Maciejek Z; Newton JL; Zalewski P
    Medicina (Kaunas); 2019 May; 55(6):. PubMed ID: 31159275
    [No Abstract]   [Full Text] [Related]  

  • 7. Offspring Number Does Not Influence Reaching the Disability's Milestones in Multiple Sclerosis: A Seven-Year Follow-Up Study.
    D'Amico E; Leone C; Patti F
    Int J Mol Sci; 2016 Feb; 17(2):234. PubMed ID: 26907250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA; Buron MD; Magyari M
    J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported levels of education and disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Van Remoortel A; De Keyser J; Nagels G
    Acta Neurol Scand; 2016 Dec; 134(6):414-419. PubMed ID: 27761897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Persistent Disability in Patients With Pediatric-Onset Multiple Sclerosis.
    Baroncini D; Simone M; Iaffaldano P; Brescia Morra V; Lanzillo R; Filippi M; Romeo M; Patti F; Chisari CG; Cocco E; Fenu G; Salemi G; Ragonese P; Inglese M; Cellerino M; Margari L; Comi G; Zaffaroni M; Ghezzi A;
    JAMA Neurol; 2021 Jun; 78(6):726-735. PubMed ID: 33938921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant autoimmunity and risk of multiple sclerosis disability worsening.
    Binzer S; Hillert J; Manouchehrinia A
    Mult Scler Relat Disord; 2024 Jul; 87():105637. PubMed ID: 38761694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol, coffee, fish, smoking and disease progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; De Keyser J
    Eur J Neurol; 2012 Apr; 19(4):616-24. PubMed ID: 22117611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients.
    Calocer F; Dejardin O; Kwiatkowski A; Bourre B; Vermersch P; Hautecoeur P; Launoy G; Defer G
    Mult Scler Relat Disord; 2020 May; 40():101930. PubMed ID: 31982665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis.
    Masera S; Cavalla P; Prosperini L; Mattioda A; Mancinelli CR; Superti G; Chiavazza C; Vercellino M; Pinessi L; Pozzilli C
    Mult Scler; 2015 Sep; 21(10):1291-7. PubMed ID: 25533293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Long-Term Outcomes of Late-Onset Multiple Sclerosis: A Swedish Nationwide Study.
    Mouresan EF; Mentesidou E; Berglund A; McKay KA; Hillert J; Iacobaeus E
    Neurology; 2024 Mar; 102(6):e208051. PubMed ID: 38394472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting.
    Trojano M; Butzkueven H; Kappos L; Wiendl H; Spelman T; Pellegrini F; Chen Y; Dong Q; Koendgen H; Belachew S;
    Mult Scler Relat Disord; 2018 Aug; 24():11-19. PubMed ID: 29860197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Kurtkze expanded disability status scale and the functional independence measure: measures of multiple sclerosis-related disability.
    Rabadi MH; Vincent AS
    Disabil Rehabil; 2013; 35(22):1877-84. PubMed ID: 23600712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of acute aggravations on the development of long-term handicap in relapsing remitting multiple sclerosis: a clinical study in 99 patients].
    Gaillard N; Fabro-Perray P; Faillie JL; Le Bayon A; Castelnovo G; Dupeyron A; Froger J; Pelissier J; Labauge P
    Rev Neurol (Paris); 2007 Jan; 163(1):72-81. PubMed ID: 17304175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.